'Quality Concerns to Resurface as FDA Resumes Foreign Inspections,'_ Bloomberg Law - March 17, 2022, quoted
'U.S. Senate narrowly confirms Dr. Robert Califf to lead FDA for second time,'_ Rueters News - February 15, 2022, quoted
'Biden's FDA Chief Confirmed by Senate With Republicans' Help,'_ Bloomberg Law - February 15, 2022, quoted
'Patent Filing By Former Employees Leads Pfizer To File Trade Secret Suit,' Pink Sheet - February 3, 2022, quoted
'FDA Wants To Make Permanent COVID-19 Supply Chain Guidance To Prevent Product Shortages,' Medtech Insight - January 11, 2022, quoted
'FDA's Pfizer Vaccine Approval Adds Fuel to Biden Booster Plan,' Bloomberg Law - August 25, 2021, featured
'Withers Picks Red-Hot Kendall Square For New Mass. Office,' Law360 - July 8, 2021, featured
'Regulatory Actions for May 19, 2021,' BioWorld - May 19, 2021, featured
'Withers Launches Venture Capital and Life Sciences Team in Boston,' Intellectual Property Magazine - April 20, 2021, featured
'News Digest: On the Move,' World Trademark Review - April 20, 2021, featured
'6 Important Elements Of The New STRONGER Patents Act,' Biosimilar Development - January 2020
'FDA Approval and Licensing as Intellectual Property,' Chapter in MCLE publication, Intellectual Property Law - January 2020
'Working the Busy Intersection of Law, Science and Business,' Corporate Counsel Business Journal - March 2019
'The ABCs of a Product Recall,' Focus Newsletter - December 2014
'Maybe it's not the real thing,' Pom Wonderful LLC v Coca-Cola Co (Supreme Court of the US) Case Analysis: Intellectual Property Magazine - July/August 2014
'State-by-State Clinical Trial Requirements Reference Guide 2013,' Barnett Educational Services, 2013
'Flurry of Supreme Court Decisions Keeps Local IP Bar Busy,' Massachusetts Lawyers Weekly, July 2014, quoted
'Managing the Risks and Regulatory Issues Associated with Successful Pharmaceutical Social Media Monitoring and Marketing,' White Paper, September 2007
